Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection By Amnon Ron|2022-03-27T20:51:22+00:00March 27th, 2022|All|Comments Off on Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: Amnon Ron Related Posts Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis
